首页> Respiration; international review of thoracic diseases> LABA/LAMA Fixed Dose Combination in Chronic Obstructive Pulmonary Disease: The Impact on Health-Related Quality of Life.

LABA/LAMA Fixed Dose Combination in Chronic Obstructive Pulmonary Disease: The Impact on Health-Related Quality of Life.

导出 LinkOut

翻译打印收藏纠错

第一作者： Marina,Labor

第一单位： Department of Pulmonology, University Hospital Center Osijek, Osijek, Croatia, Faculty of Medicine, J.J. Strossmayer University of Osijek, Osijek, Croatia.

作者： Marina,Labor ^[1] ; Fulvio,Braido ^[2] ; Andras,Bikov ^[3] ; Lies,Lahousse ^[4] ; Paola,Rogliani ^[5] ; Ilaria,Baiardini ^[6]

作者单位： Department of Pulmonology, University Hospital Center Osijek, Osijek, Croatia, Faculty of Medicine, J.J. Strossmayer University of Osijek, Osijek, Croatia. ^[1] Department of Internal Medicine, Respiratory Diseases and Allergy Clinic, University of Genova, Azienda Policlinico IRCCs San Martino, Genoa, Italy. ^[2] NIHR Manchester Clinical Research Facility, Manchester University NHS Foundation Trust, Manchester, United Kingdom. ^[3] Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium. ^[4] Dipartimento di Medicina Sperimentale e Chirurgia Università di Roma "Tor Vergata,", Roma, Italy. ^[5] Department of Biomedical Sciences, Humanitas University, Milano, Italy. ^[6]

关键词 Chronic obstructive pulmonary disease treatment Health-related quality of life Long-acting beta 2-agonists /long-acting muscarinic antagonists fixed dose combinations Patient reported outcomes Randomized controlled trials

医学主题词肾上腺素能β-2受体激动剂(Adrenergic beta-2 Receptor Agonists);复方合剂(Drug Combinations);人类(Humans);毒蕈碱拮抗剂(Muscarinic Antagonists);肺疾病, 慢性阻塞性(Pulmonary Disease, Chronic Obstructive);生活质量(Quality of Life)

DOI 10.1159/000491673

PMID 30227433

发布时间 2019-10-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交